Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Mayo Clinic Proceedings|October 4, 2011
Corticosteroids in the treatment of alcohol-induced rhabdomyolysisJames W Antoon, Chayan ChakrabortiBioorganic & Medicinal Chemistry Letters|February 28, 2012
Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancerJames W Antoon, Barbara S BeckmanJournal of Pediatric Hematology/Oncology|March 8, 2016
Evans Syndrome Secondary to Common Variable Immune DeficiencyJames W Antoon, Diana Metropulos, Benny L JoynerThe Journal of Allergy and Clinical Immunology. in Practice|January 18, 2018
Prevalence and Outcomes of Primary Immunodeficiency in Hospitalized Children in the United StatesZachary Rubin, Andrea Pappalardo, Alan Schwartz, et al.Pediatric Dermatology|January 10, 2018
Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysisJames W Antoon, Jennifer L Goldman, Brian Lee, et al.JEM Reports|March 3, 2023
Croup associated with COVID-19: A case seriesJessica Hayes, Marla Levine, S Barron Frazier, et al.Anticancer Research|September 12, 2013
Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640Martin D White, Lucas Chan, James W Antoon, et al.The Journal of Allergy and Clinical Immunology. in Practice|June 3, 2018
A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal NecrolysisJames W Antoon, Jennifer L Goldman, Samir S Shah, et al.Pharmacological Reports : PR|June 7, 2014
Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survivalMatthew M Gestaut, James W Antoon, Matthew E Burow, et al.Bioorganic & Medicinal Chemistry|July 20, 2010
Novel anti-viability ceramide analogs: design, synthesis, and structure-activity relationship studies of substituted (S)-2-(benzylideneamino)-3-hydroxy-N-tetradecylpropanamidesJiawang Liu, James W Antoon, Adharsh Ponnapakkam, et al.Pageof 9